PuraMed BioScience, Inc. (PMBS.OB) Retains Media4Equity for 12-Month Multimedia Campaign
PuraMed BioScience Inc. engages in the research, development and marketing of non-prescription medicines and healthcare products. Its leading product is LipiGesic M, which provides acute relief from migraine headaches. The company also has plans to launch LipiGesic PM, which provides a remedy for insomnia and other sleep disorders as well as LipiGesic H for common tension headaches. The company announced today that it has entered into an agreement with Media4Equity and its parent company, NewsUSA, for a multimedia marketing campaign over the next year. Media4Equity uses its media and marketing clout and contacts to help strong emerging growth companies grow…